Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy
- Resource Type
- Article
- Authors
- Wang, Eunice S. ; Montesinos, Pau; Minden, Mark D.; Lee, Je-Hwan; Heuser, Michael; Naoe, Tomoki; Chou, Wen-Chien; Laribi, Kamel; Esteve, Jordi; Altman, Jessica K.; Havelange, Violaine; Watson, Anne-Marie; Gambacorti-Passerini, Carlo; Patkowska, Elzbieta; Liu, Shufang; Wu, Ruishan; Philipose, Nisha; Hill, Jason E.; Gill, Stanley C.; Rich, Elizabeth Shima; Tiu, Ramon V.
- Source
- In Blood 27 October 2022 140(17):1845-1857
- Subject
- Clinical Trials and Observations
Free Research Articles
Myeloid Neoplasia
- Language
- ISSN
- 0006-4971